FDA Approval of Remdesivir - A Step in the Right Direction

Abstract

On October 22, 2020, on the basis of the results of three phase 3 clinical trials, the FDA approved remdesivir for use in adults and pediatric patients (12 years of age or older and weighing at least 40 kg) for the treatment of Covid-19 requiring hospitalization.